|
|
|
|
|
The Niche
|
Stem Cell & Regenerative Med Newsletter
|
|
|
|
|
|
Weekly reads: stem cells for MS, Kimera Labs IND, FDA lawsuit
|
|
|
|
There has been a steady stream of encouraging data on stem cells for MS. Particularly for certain kinds of MS. A new study adds to this upbeat direction. Good news on stem cells for MS Haematopoietic stem cell transplantation for treatment of relapsing-remitting multiple sclerosis in Sweden: an observational cohort study, Journal of Neurology, Neurosurgery, and Psychiatry. This paper is …
|
|
|
|
|
|
|
|
BrainStorm Cell Therapeutics Hail Mary with FDA on Nurown for ALS
|
|
|
|
BrainStorm Cell Therapeutics is developing Nurown, an investigational therapy intended for treating ALS. I recently posted about BrainStorm and its prospects for providing real hope on stem cells for ALS. I see it as a long shot. The ALS community needs real hope, but one challenge is determining how good clinical data have to be to allow FDA approval. BrainStorm Cell …
|
|
|
|
|
|
